Drusolv Therapeutics
PrivateLast Round
Series A
May 30, 2023
Total Funding Raised
$2.5M
Company Overview
Drusolv Therapeutics operates in Healthcare & Life Sciences and is based in Philadelphia, Pennsylvania. Its latest recorded funding round was a Seed round in April 2022.
Drusolv Therapeutics is a drug discovery company that is developing a high-dose oral statin for early intervention in age-related macular degeneration (AMD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Drusolv Therapeutics Comparables
Compare Drusolv Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InflammX Therapeutics | 88% | |
| Allegro Ophthalmics | 80% | |
| Morningside | 76% |
For institutional investors. Book with your work email.
Drusolv Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 30, 2023 | ||||
| Seed | Apr 12, 2022 | ||||
| Grant | Mar 31, 2022 |
For institutional investors. Book with your work email.
Drusolv Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BrightFocus Foundation | Seed, Grant, Series A |
| Texas Halo Fund | Seed, Series A |
Drusolv Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Drusolv Therapeutics's valuation, stock price, and market status.
Is Drusolv Therapeutics a public or private company?
Drusolv Therapeutics is a private company.
What is the current stock price of Drusolv Therapeutics?
Drusolv Therapeutics is a private company, so its shares have no public market price. Caplight tracks Drusolv Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Drusolv Therapeutics worth (valuation)?
Valuation information for Drusolv Therapeutics is not publicly available.
Can I buy Drusolv Therapeutics stock?
Drusolv Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Drusolv Therapeutics's last funding round?
Drusolv Therapeutics's most recent funding round was Series A on May 30, 2023.
Who are the main investors in Drusolv Therapeutics?
Key investors in Drusolv Therapeutics include BrightFocus Foundation, Texas Halo Fund.
Will Drusolv Therapeutics IPO soon?
No public IPO plans have been announced for Drusolv Therapeutics.
How can I track Drusolv Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Drusolv Therapeutics's shares on secondary markets.